The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma. Donovan C, Thorpe AE, Gomez HM, Carroll OR, et al. Am J Respir Cell Mol Biol 2024;70:424-427.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Donovan C, Thorpe AE, Gomez HM, Carroll OR, et al. The GPR84 Antagonist GLPG1205 Reduces Features of Disease in Experimental Severe Asthma. Am J Respir Cell Mol Biol 2024;70:424-427.
PMID: 38690993